Drug Trial Radar · NCT07731685
A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases
Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
26
Planned (sponsor's estimate)
Start
Jul 30, 2026
Primary completion
Dec 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTDIndustry
- Sponsor type
- Industry
- First posted
- Jul 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled Phase Ib study evaluating the safety and efficacy of VC004 capsules for the relief of moderate-to-severe pain associated with bone metastases
Conditions
- Pain in Bone Metastases
Interventions
VC004 low doseDrug
VC004 low dose BID
VC004 high doseDrug
VC004 high dose BID
VC004 placeboDrug
VC004 placebo BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the daily average pain intensity Numeric Rating Scale (NRS) scoreTime frame: At Week 1, Week 2 and Week 4
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Zhongda Hospital,Affiliated to Southeast University
Nanjing, Jiangsu, China
Zhongda Hospital,Affiliated to Southeast University
Nanjing, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.